ACTIVE DRUG INGREDIENT, DRUG, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF DEMYELINATING DISEASES OF LIVING ORGANISM, INCLUDING DISEASE PREVENTION Russian patent published in 2017 - IPC A61K31/765 A61K31/45 A61K36/15 A61P25/32 A61P25/00 

Abstract RU 2631887 C2

FIELD: pharmacology.

SUBSTANCE: invention is a drug for treatment of diseases of a living organism associated with inflammatory demyelination, represented by polyprenols derived from coniferous tree species of the general formula

This invention also includes a method for treatment of diseases of a living organism associated with inflammatory demyelination, characterised by introduction of an effective amount of polyprenols of the general formula (1) into the living organism to enhance myelination and formation of young neurons in white and gray brain material.

EFFECT: invention has a double positive effect in demyelinating conditions, namely it has a remyelinating effect, accelerates the process of neurogenesis, and also has an immunomodulating metabolic action, as well as allows to obtain a minimal side effect when using a medicinal product of plant origin.

4 cl, 10 dwg, 2 tbl, 5 ex

Similar patents RU2631887C2

Title Year Author Number
MEDICINAL AGENT FOR ETHYL ALCOHOL AND/OR NARCOTIC ADDICTION TREATMENT, PARMACEUTICAL COMPOSITION, ACTIVE INGREDIENT OF PHARMACEUTICAL COMPOSITION, METHOD OF ETHYL ALCOHOL AND/OR NARCOTIC ADDICTION TREATMENT FOR ALCOHOLICS' AND/OR NARCOTISTS' PSYCHOSOMATIC AND NEUROLOGICAL COMPLICATION TREATMENT 2007
  • Roshchin Viktor Ivanovich
  • Sultanov Vagif Sultanovich
RU2327448C1
MONOAMINOOXIDASE INHIBITORS, THERAPEUTIC AGENT AND PHARMACEUTICAL COMPOSITION 2007
  • Roshchin Viktor Ivanovich
  • Sultanov Vagif Sultanovich
RU2366430C2
ACTIVE INGREDIENT OF MEDICINAL AGENT, MEDICINAL AGENT, PHARMACEUTICAL CONPOSITION AND METHOD OF DEMENT SYNDROME TREATMENT 2007
  • Roshchin Viktor Ivanovich
  • Sultanov Vagif Sultanovich
RU2327480C1
TREATMENT OF DEMYELINATING DISEASES 2019
  • Kivell, Bronvin Mari
  • La Flamme, Anna Kamilla
  • Prisintsano, Tomas Edvard
RU2805061C2
ANIMAL MODEL EXPRESSING LUCIFERASE UNDER CONTROL OF THE MYELIN BASIC PROTEIN PROMOTER (MBP-LUCI) AND USE OF THE MODEL FOR BIOLUMINESCENCE IN VIVO IMAGING 2010
  • Tsao Dzhejms
  • Chandross Karen
  • Ekonomidis Kiriyakos D.
  • Poulits Garri Gregori
  • Vejnstok Deniel
  • In Syaoyu
RU2601128C2
PHARMACEUTICAL PREPARATION FOR TREATING DEMYELINATING DISEASES OF NERVOUS SYSTEM, PREPARATION FAVOURING RECOVERY OF MYELIN SHEATH OF NERVE FIBRE, AND METHOD OF TREATING DEMYELINATING DISEASES OF NERVOUS SYSTEM 2007
  • Arzamastsev Evgenij Veniaminovich
  • Malinovskaja Klavdija Ignat'Evna
  • Mironova Margarita Ivanovna
RU2355413C1
NEW METHODS FOR TREATING MULTIPLE SCLEROSIS 2018
  • Shimshek, Derya
RU2765820C2
METHODS AND TREATMENT OF CERTAIN DISORDERS BASED ON DEMYELINATION AND DEMYELINATION AND/OR REMYELINATION STIMULATION 2014
  • Chzhan, Chzhunyan
  • Mortenson, Mark G.
RU2686677C2
MEDICINAL AGENT, A PHARMACEUTICAL COMPOSITION, AN ACTIVE INGREDIENT OF THE PHARMACEUTICAL COMPOSITION AND A METHOD OF TREATING COGNITIVE DISORDERS IN THE PATIENTS SUFFERING ACUTE MYOCARDIAL INFARCTION 2018
  • Sultanov Vagif Sultanovich
  • Vyshlov Evgenij Viktorovich
  • Tsoj Ekaterina Igorevna
  • Trusov Vladimir Borisovich
  • Lebedeva Elena Vladimirovna
RU2702127C1
MEDICINAL AGENT, A PHARMACEUTICAL COMPOSITION, AN ACTIVE INGREDIENT OF THE PHARMACEUTICAL COMPOSITION AND A METHOD OF TREATING ANXIETY AND DEPRESSION IN THE PATIENTS WITH ACUTE MYOCARDIAL INFARCTION 2018
  • Sultanov Vagif Sultanovich
  • Vyshlov Evgenij Viktorovich
  • Tsoj Ekaterina Igorevna
  • Trusov Vladimir Borisovich
  • Lebedeva Elena Vladimirovna
RU2702128C1

RU 2 631 887 C2

Authors

Sultanov Vagif Sultanovich

Nikitina Tamara Valentinovna

Khodanovich Marina Yurevna

Dates

2017-09-28Published

2015-09-07Filed